River Global Investors LLP Acquires 5.2% Stake in MaxCyte, Inc.

River Global Investors LLP has filed a Schedule 13D with the SEC, disclosing a 5.2% ownership stake in MaxCyte, Inc. The filing indicates that River Global Investors LLP acquired 5,497,452 shares of MaxCyte's equity, representing 5.1568% of the class. The transactions were conducted on Bloomberg AIM, with purchases made at various prices. The filing also states that the purpose of the transaction is the acquisition of additional securities of the issuer. River Global Investors LLP, based in London, United Kingdom, has sole voting and dispositive power over the shares. The filing was signed by Nusayhah Ghaboos, Operational Compliance Associate, on behalf of River Global Investors LLP.